Nimmune Biopharma, Inc.

United States of America

Create a watch for Nimmune Biopharma, Inc.
Total IP 25
Total IP Rank # 60,283
IP Activity Score 2.1/5.0    17
IP Activity Rank # 49,201

Patents

Trademarks

20 0
5 0
0 0
0
 
Last Patent 2025 - Therapies with lanthionine c-lik...
First Patent 2015 - Lanthionine synthetase c-like 2-...

Latest Inventions, Goods, Services

2024 Invention Therapies with lanthionine c-like protein 2 ligands and cells prepared therewith. Provided are c...
Invention Lanthionine c-like protein 2 ligands, cells prepared therewith, and therapies using same. Provid...
2022 Invention Lanthionine synthetase c-like 2-based therapeutics. Provided are compounds that target the lanthi...
Invention Crystalline forms of piperazine-1,4-diylbis((6-(1h-benzo[d]imidazo-2-yl)pyridin-2yl)methanone). C...
Invention Lancl ligands. Provided are compounds of Formula (I): The compounds target the lanthionine s...
Invention Lanthionine c-like protein 2 ligands, cells prepared therewith, and therapies using same. Provide...
2021 Invention Compounds, compositions, and methods for treating inflammatory or immune-mediated conditions of s...
Invention Therapies with lanthionine c-like protein 2 ligands and cells prepared therewith. Provided are co...